May 13, 2010 — Eltrombopag (Promacta; GlaxoSmithKline) has been linked to an increased risk for portal venous thrombosis in patients with thrombocytopenia due to chronic liver disease, and the company ...

Actively identifying the risk factors and predictive indicators associated with portal vein thrombosis (PVT) in liver cirrhosis (LC) can enable early diagnosis and treatment, which is of great ...

Portal vein thrombosis (PVT) is a blood clot of the portal vein, also known as the hepatic portal vein. A PVT blocks the blood flow from the intestines to the liver. Although it is treatable, PVT can ...

APPLICATION of the technics of hepatic-vein catheterization and percutaneous splenic puncture, with appropriate blood-flow and pressure measurements and radiologic visualization of the portal bed, has ...

Veins are a type of blood vessel that return deoxygenated blood from your organs back to your heart. These are different from your arteries, which deliver oxygenated blood from your heart to the rest ...

The treatment of hepatocellular carcinoma with macrovascular invasion, including portal vein tumor thrombus, remains challenging to treat and has poor outcomes. Approximately 20% of patients with ...

To compare the survival outcomes of neoadjuvant three-dimensional conformal radiotherapy (RT) followed by hepatectomy with hepatectomy alone in patients with hepatocellular carcinoma (HCC) and portal ...